The Effect of Intrahepatic and Intrasplenic Administration of Mesenchymal Stem Cell to Liver Function and Degree of Liver Fibrosis in Common Bile Duct Ligation Model in Rabbit
Topic overview
This experimental study compares intrahepatic versus intrasplenic delivery of mesenchymal stem cells in a rabbit model of bile duct obstruction-induced liver fibrosis. The research evaluates which administration route more effectively improves liver function and reduces fibrosis severity.
Key takeaways
- Mesenchymal stem cells show promise as an alternative treatment for liver cirrhosis management.
- Multiple MSC administration routes exist, but comparative efficacy data between routes remains limited.
- Intrahepatic and intrasplenic routes are being compared for MSC delivery in bile duct ligation models.
- Study endpoints include liver function parameters and quantitative assessment of liver fibrosis degree.
- Rabbit bile duct ligation model serves as translational research platform for cirrhosis therapeutics.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. The Effect of Intrahepatic and Intrasplenic Administration of Mesenchymal Stem Cell to Liver Function and Degree of Liver Fibrosis in Common Bile Duct Ligation Model in Rabbit. GlobalCastMD Medical Library. 2023-12-08. https://library.globalcastmd.com/article/8278
Comments